Gestora
GESIURIS ASSET MANAGEMENT, SGIIC, S.A.
Ver el universo de gestoras de la CNMV →
Ficha de fondo
GESIURIS PATRIMONIAL, FI
Categoria
—
Ultimo periodo
2S 2025
Posiciones
70
Cartera notificada con cierre 2025-12-31. Fuente: informe periodico en la CNMV. Ver informe original (PDF)
Cartera completa
Todas las posiciones del ultimo informe periodico, de mayor a menor peso. Los agregados ("resto de renta variable...") son cestas de posiciones pequenas que el propio informe no desglosa linea a linea.
70
Empresa
Tipo
Pais
Peso
Precio
Movimientos del periodo
2S 2025 frente a 1S 2025 (estimada)
Nuevas: 26
Salidas: 27
Incrementos: 17
Recortes: 2
+ ACCIONES|DEUTSCHE BOERSE AG
Entra en la cartera con un 0.56% de peso.
Deutsche Börse AG operates as an international exchange organization in Germany, rest of Europe, the United States, and the Asia-Pacific. The company operates through four segments: Investment Management Solutions, Trading & Clearing, Fund Services, and Securities Services. The Investment Management Solutions segment offers financial data, analytics, and software-as-a-service solutions including research, data collection, data analysis, and the provision of indices, analytics and investment management software to institutional investors, banks, and corporate clients. The Trading & Clearing segment engages in the development and operation of markets and trading systems for securities, derivatives, commodities, currencies, digital assets, and other asset classes. This segment handles settlement of transactions through clearing houses. Its Fund Services segment provides infrastructure and services for fund processing, including order routing, settlement, custody, data and distribution support for investment funds. The Securities Services segment offers various services for securities issuance, settlement, custody as well as collateral, securities lending, and liquidity management. The company was founded in 1585 and is headquartered in Eschborn, Germany.
Ver ficha de la empresa →− NESTLE HOLDING INC
Sale de la cartera; tenia un 3.59% de peso.
− DEUDA ESTADO USA
Sale de la cartera; tenia un 3.08% de peso.
− ACCIONES|REPSOL SA
Sale de la cartera; tenia un 2.65% de peso.
− CITIGROUP INC
Sale de la cartera; tenia un 1.97% de peso.
− REPSOL INTL FINANCE
Sale de la cartera; tenia un 1.97% de peso.
− MEDTRONIC GBLHOLDING
Sale de la cartera; tenia un 1.95% de peso.
− PORSCHE
Sale de la cartera; tenia un 1.70% de peso.
− BANK OF AMERICA
Sale de la cartera; tenia un 1.30% de peso.
− ACCIONES|ASML HOLDING NV
Sale de la cartera; tenia un 1.11% de peso.
− ACCIONES|DEUTSCHE TELEKOM AG
Sale de la cartera; tenia un 1.02% de peso.
− ACCIONES|AIRBUS GROUP NV
Sale de la cartera; tenia un 0.99% de peso.
Airbus SE, together with its subsidiaries, engages in the design, manufacture, and delivery of aeronautics and aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft, freighter aircraft, regional turboprop aircraft, and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment develops, manufactures, markets, and sells civil and military helicopters; and provides uncrewed aerial systems and their related services. The Airbus Defence and Space segment designs, develops, delivers, and supports crewed and uncrewed military air systems and related services. This segment also offers civil and defence space systems for telecommunications, earth observations, navigation, and science and orbital systems; and services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. The company was incorporated in 1998 and is headquartered in Leiden, the Netherlands.
Ver ficha de la empresa →− ACCIONES|SAMSUNG ELECTRONICS
Sale de la cartera; tenia un 0.98% de peso.
− ABERTIS
Sale de la cartera; tenia un 0.98% de peso.
− METROVACESA
Sale de la cartera; tenia un 0.97% de peso.
− CIE AUTOMOTIVE SA
Sale de la cartera; tenia un 0.97% de peso.
− CIE AUTOMOTIVE SA
Sale de la cartera; tenia un 0.95% de peso.
− ACCIONA
Sale de la cartera; tenia un 0.95% de peso.
− INMOB.COLONIAL, S.A.
Sale de la cartera; tenia un 0.94% de peso.
− ACCIONES|JOHNSON & JOHNSON
Sale de la cartera; tenia un 0.94% de peso.
− ACCIONES|TESLA MOTORS INC
Sale de la cartera; tenia un 0.88% de peso.
− ACCIONA
Sale de la cartera; tenia un 0.65% de peso.
− ACCIONES|EDP RENOVAVEIS SA
Sale de la cartera; tenia un 0.44% de peso.
− AT&T INC
Sale de la cartera; tenia un 0.33% de peso.
− VIDRALA SA
Sale de la cartera; tenia un 0.33% de peso.
− ALMIRALL LABORATORIO
Sale de la cartera; tenia un 0.32% de peso.
− GLOBAL DOMINION
Sale de la cartera; tenia un 0.32% de peso.
− ACCIONES|HALOZYME THERAPEUTIC
Sale de la cartera; tenia un 0.28% de peso.
▲ ACCIONES|GRIFOLS
Pasa del 1.70% al 2.75%.
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.
Ver ficha de la empresa →▲ ACCIONES|VIATRIS INC
Pasa del 0.54% al 1.11%.
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
Ver ficha de la empresa →Renta fija
Exposición RF declarada
15.0 M €
% de la cartera
53.3%
Posiciones
40
Emisores
34
Soberano: 0 €
Corporativo: 15.0 M €
Escalera de vencimientos
Vencimiento contractual observado de cada posición, sin repos. Vencido/≤3 meses incluye bonos que vencen en los primeros días tras el cierre del periodo.
Vencido o ≤3 meses · 7.2%3-6 meses · 3.9%6-12 meses · 37.2%1-2 años · 23.7%2-5 años · 28.1%
Vencimiento
Posiciones
Exposición
%
Vencido o ≤3 meses
3
1.1 M €
7.2%
3-6 meses
4
591,678 €
3.9%
6-12 meses
13
5.6 M €
37.2%
1-2 años
9
3.5 M €
23.7%
2-5 años
11
4.2 M €
28.1%
5-10 años
0
0 €
0.0%
> 10 años
0
0 €
0.0%
Desconocido
0
0 €
0.0%
Top emisores
Los 10 emisores con mayor exposición declarada en este fondo, sin repos.
Emisor
Tipo
Nº ISIN
Exposición
Próximo vencimiento
BNP PARIBAS SA
Corporativo
2
1.2 M €
2027-01-23
MORGAN STANLEY
Corporativo
1
1.2 M €
2027-03-19
NETFLIX INC
Corporativo
2
1.1 M €
2026-11-15
J.P.MORGAN
Corporativo
1
1.1 M €
2026-10-01
MOODY´S CORP
Corporativo
2
1.0 M €
2027-03-09
ARCELOR MITTAL
Corporativo
1
723,566 €
2026-09-26
AMGEN INC
Corporativo
1
682,250 €
2026-02-25
GOLDMAN SACHS
Corporativo
1
596,589 €
2026-07-27
NASDAQ INC
Corporativo
1
570,559 €
2029-03-28
HERA SPA
Corporativo
1
490,505 €
2026-10-14
Top instrumentos
Los 10 instrumentos con mayor exposición declarada. Sin yield, TIR ni rating: no hay dato fiable para calcularlos.
ISIN
Cupón
Vencimiento
Exposición
XS2790333616 MORGAN STANLEY
2.70%
2027-03-19
1.2 M €
US46625HRV41 J.P.MORGAN
2.95%
2026-10-01
1.1 M €
XS2537060746 ARCELOR MITTAL
4.88%
2026-09-26
723,566 €
XS2010038227 MOODY´S CORP
0.95%
2030-02-25
720,358 €
US64110LAN64 NETFLIX INC
4.38%
2026-11-15
683,376 €
XS1369278764 AMGEN INC
2.00%
2026-02-25
682,250 €
FR001400CFW8 BNP PARIBAS SA
3.63%
2029-09-01
611,524 €
FR0013398070 BNP PARIBAS SA
2.13%
2027-01-23
598,151 €
XS1458408561 GOLDMAN SACHS
1.63%
2026-07-27
596,589 €
XS1843442622 NASDAQ INC
1.75%
2029-03-28
570,559 €
Divisas
Exposición RF por divisa del instrumento.
Divisa
Exposición
%
EUR
12.7 M €
84.9%
USD
2.3 M €
15.1%
Movimientos de renta fija del periodo
Compara la cartera RF actual con la del periodo anterior, por ISIN. Una salida coincidente con vencimiento no es una venta: el bono llegó a su fecha contractual.
Nuevas posiciones: 23
Salidas por vencimiento: 14
Salidas no explicadas por vencimiento: 4
+ GOLDMAN SACHS
Entra en la cartera con un 2.12% de peso.
+ ENEL SPA
Entra en la cartera con un 1.47% de peso.
+ ACCIONA
Entra en la cartera con un 1.39% de peso.
+ MASTERCARD INC
Entra en la cartera con un 1.34% de peso.
+ ABERTIS
Entra en la cartera con un 1.11% de peso.
+ L´OREAL SA
Entra en la cartera con un 1.07% de peso.
+ MOODY´S CORP
Entra en la cartera con un 1.06% de peso.
+ BARCELO CORP EMPRESA
Entra en la cartera con un 1.04% de peso.
+ PROSEGUR CASH
Entra en la cartera con un 1.04% de peso.
+ INMOB.COLONIAL, S.A.
Entra en la cartera con un 1.02% de peso.
+ MCDONALD´S CORP
Entra en la cartera con un 0.90% de peso.
+ PROCTER & GAMBLE CO
Entra en la cartera con un 0.90% de peso.
+ COCA-COLA HBC FINANC
Entra en la cartera con un 0.72% de peso.
+ GRIFOLS
Entra en la cartera con un 0.70% de peso.
+ METROVACESA
Entra en la cartera con un 0.70% de peso.
+ AFRICAN DEVELOPMENT
Entra en la cartera con un 0.70% de peso.
+ GESTAMP AUTOMOCION S
Entra en la cartera con un 0.69% de peso.
+ CAIXABANK SA
Entra en la cartera con un 0.36% de peso.
+ BMW INTL INVEST BV
Entra en la cartera con un 0.36% de peso.
+ GLOBAL DOMINION
Entra en la cartera con un 0.35% de peso.
+ GLOBAL DOMINION
Entra en la cartera con un 0.35% de peso.
+ CIE AUTOMOTIVE SA
Entra en la cartera con un 0.35% de peso.
+ GESTAMP AUTOMOCION S
Entra en la cartera con un 0.35% de peso.
− CITIGROUP INC
Sale de la cartera; tenía un 1.97% de peso.
− PORSCHE
Sale de la cartera; tenía un 1.70% de peso.
− BANK OF AMERICA
Sale de la cartera; tenía un 1.30% de peso.
− ALMIRALL LABORATORIO
Sale de la cartera; tenía un 0.32% de peso.
◦ NESTLE HOLDING INC
Sale de la cartera; tenía un 3.59% de peso.
◦ DEUDA ESTADO USA
Sale de la cartera; tenía un 3.08% de peso.
◦ REPSOL INTL FINANCE
Sale de la cartera; tenía un 1.97% de peso.
◦ MEDTRONIC GBLHOLDING
Sale de la cartera; tenía un 1.95% de peso.
◦ ABERTIS
Sale de la cartera; tenía un 0.98% de peso.
◦ METROVACESA
Sale de la cartera; tenía un 0.97% de peso.
◦ CIE AUTOMOTIVE SA
Sale de la cartera; tenía un 0.97% de peso.
◦ CIE AUTOMOTIVE SA
Sale de la cartera; tenía un 0.95% de peso.
◦ ACCIONA
Sale de la cartera; tenía un 0.95% de peso.
◦ INMOB.COLONIAL, S.A.
Sale de la cartera; tenía un 0.94% de peso.
◦ ACCIONA
Sale de la cartera; tenía un 0.65% de peso.
◦ AT&T INC
Sale de la cartera; tenía un 0.33% de peso.
◦ VIDRALA SA
Sale de la cartera; tenía un 0.33% de peso.
◦ GLOBAL DOMINION
Sale de la cartera; tenía un 0.32% de peso.
Aviso
Esto no es asesoramiento financiero. La cartera procede del informe periodico que el fondo presenta en la CNMV y llega con retraso respecto al cierre real del periodo: es una foto del final de cada semestre, no la cartera en tiempo real.